This study was done to evaluate whether anti-Chlamydia pneumoniae seropositivity can be
a predictor of restenosis after coronary intervention. Recent studies indicate that latent …

Background: The aim of this study was to establish whether Chlamydia pneumoniae is
implicated in the development of restenosis in patients with coronary heart disease (CHD) …

Objectives: The potential role of common infectious agents in the pathogenesis and
progression of atherosclerosis has been studied increasingly over the last decade. The …

Chlamydia pneumoniae is frequently found in atherosclerotic lesions, and high titers of
specific antibodies are associated with increased risk for acute myocardial infarction …

Mattila KJ, Juvonen JT, Kotamäki MK, Saikku PA (Helsinki University Hospital, Helsinki;
Kainuu Central Hospital, Kajaani, and National Public Health Institute, Oulu, Finland) …

Aims: Since infection of endothelial or smooth muscle cells with Chlamydia pneumoniae
increased expression of tissue factor and plasminogen activator inhibitor I (PAI-1), C …

BACKGROUND: Previous studies have shown an incremental role of inflammation in late
prognosis following coronary stenting (CS). In particular, high preprocedural levels of …

BACKGROUND: Elevated antibodies against Chlamydia pneumoniae have been
associated with coronary artery disease. In patients undergoing percutaneous coronary …

Background: Chlamydia pneumoniae has been associated with coronary artery disease by
both seroepidemiological studies, and by direct detection of the micro-organism in …

We recently showed that Chlamydia pneumoniae activates platelets in vitro, with an
associated oxidation of low-density lipoproteins. The aim of this study was to investigate …